Latham Advises on US$85 Million Financing for SPR Therapeutics

SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, has announced that it has secured US$85 million in financing including US$25 million in equity and a US$60 million debt facility. The debt facility is provided by SLR Capital Partners. Armentum Partners served as the Company’s financial advisor.

Latham represented SLR Capital Partners with a deal team led by partners Haim Zaltzman and Dan Van Fleet, with associates Axel Magnusson and Tyler Davis. Advice was also provided on tax matters by partner Eric Cho; on healthcare regulatory matters by partner Chad Jennings; and on security and intercreditor matters by counsel Emily Leong Yu.